[May 07, 2014]

Research and Markets: Myocardial Infarction Therapeutics Pipeline Review 2014 - Analysis of 55 Companies & 108 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/494gbf/myocardial) has announced the addition of the "Myocardial Infarction - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutc development for Myocardial Infarction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myocardial Infarction and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

For more information visit http://www.researchandmarkets.com/research/494gbf/myocardial

[ Back To TMCnet.com's Homepage ]